Tianjin Ringpu shareholder completes internal stock transfer

Tianjin Ringpu Bio-Technology Co., Ltd. announced the completion of an internal share transfer by Mr. Liang Wu, a shareholder holding over 5% of the company's shares. The transfer involved 311,320 shares, representing 0.067% of the total share capital, moved from Mr. Liang Wu to Turing Private Equity Fund Management (Hainan) Co., Ltd. - Turing Makyfield No. 6 Private Investment Fund. The transaction, executed via block trade, took place on 2025/9/25 at a price of CNY 17 per share.

This internal transfer, initially disclosed on 2025/7/11, adheres to the previously announced plan. Notably, despite the reallocation of shares, the total aggregated shareholding of Mr. Liang Wu and his parties acting in concert remains unchanged at 7.00% of the company's total share capital, totaling 32,532,221 shares. This movement is an internal adjustment and does not constitute a reduction in overall market holdings by the group.

The company confirmed that the internal transfer complies with relevant securities laws and regulations, including the "Securities Law of the People's Republic of China" and the "Interim Measures for the Administration of Shareholders' Share Reduction in Listed Companies." Investors are advised to exercise caution and prudence when making investment decisions.